Azetukalner

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameAzetukalner
Drug Alias NameEncukalnerVRX-621698VRX-6981OP-2198XEN-1101 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv7.2 agonistsPotassium voltage-gated channel subfamily KQT member 3 activators
TargetsVoltage-gated potassium channel subunit Kv7.2Potassium voltage-gated channel subfamily KQT member 3
Therapy Area/IndicationsBipolar II DisorderBipolar I DisorderDepressive Disorder, Major +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[30] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesValeant
China Registration ClassN/A

Develop Information

Active CompaniesXenon Pharmaceuticals IncNational Institute Of Mental Health (Nimh)
Inactive CompaniesN/A
Active IndicationsBipolar II DisorderBipolar I DisorderDepressive Disorder, Major +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG